CORPORATE UPDATE - CSE:OVAT / OTCQB: OVATF www.OvationScience.com
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
CORPORATE UPDATE
Topical and Transdermal Skin Delivery Technology
Backed By Science / Protected By Patents
CSE:OVAT / OTCQB: OVATF
www.OvationScience.com 2021
SAFE HARBOR
STATEMENT
T H I S P R E S E N TA T I O N B E L O N G S E X C L U S I V E LY T O O V A T I O N S C I E N C E I N C . I T
D O E S N O T I M P LY A N O F F E R I N G O F S E C U R I T I E S .
F O R W A R D - L O O K I N G S TA T E M E N T S :
T H I S P R E S E N TA T I O N C O N TA I N S F O R W A R D - L O O K I N G S TA T E M E N T S W I T H I N
THE MEANING OF SECTION 27A OF THE SECURITIES ACT OF 1933 AND
SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934. ACTUAL
R E S U L T S C O U L D D I F F E R M A T E R I A L LY F R O M T H O S E P R O J E C T E D I N T H E
F O R W A R D - L O O K I N G S TA T E M E N T S A S A R E S U L T O F T H E R I S K - R E L A T E D
FA C TO R S S E T F O R T H H E R E I N .
N O T F O R D I S S E M I N AT I O N I N T H E U S A
NOTE: OVATION does not sell or distribute any products that are in violation of the
United States Controlled Substances Act (US.CSA). The company does sell its
Invisicare polymer to its licensees.
OVATION SCIENCE INC. – ABOUT US
Ovation Science Inc. (“Ovation”) is a topical and transdermal product development
company with Invisicare®, a patented skin drug delivery technology backed by over 20
years of research and development .
WE ARE ALL ABOUT OUR SCIENCE!
Ovation sells and licenses its highly effective health & wellness products globally in two
distinct categories including:
DermSafe®; a unique hand
Highly effective topical and
#1 #2 sanitizer without alcohol that
transdermal cannabis products (CBD,
is helping fight the battle
THC & hemp seed oil). Over 30
against COVID-19
products developed for wellness &
globally.
beauty.
Global CBD Global Hand
Skincare Sanitizer
Market 2020: Market 2020:
$0.9B** $3.3B*
*according to a report from Grand View Research
**according to a report from Allied Market Research
SALES AND FINANCIALS
$350,000 120%
$300,000
100%
$250,000
80%
$200,000
60%
$150,000
40%
$100,000
20%
$50,000
$- 0%
FY2019 Q3 FY2019 Q4 FY2020 Q1 FY2020 Q2 FY2020 Q3
Revenue Cost of sales Gross margin Gross margin %
NOTABLE DEVELOPMENTS:
GROSS MARGIN: Between 50 – 100% each quarter 2019/20
§ FY2020 Q1:
§ First batch of DermSafe® hand sanitizer sold
§ Coronavirus pandemic generates increased demand and orders for DermSafe® hand
sanitizer
§FY2020 Q2:
§ COVID-19 related dispensary closures begin to impact sales
§FY2020 Q3:
§ Gradual reopening in some areas from COVID-19 related closures
INVESTMENT HIGHLIGHTS
OVATION SCIENCE INC.
GLOBAL TARGET GLOBAL MARKETS: Targeting diversified growing markets &
MARKETS global prospects
MULTIPLE REVENUE DIVERSE REVENUE STREAMS: Revenue growth potential
STREAMS from product sales, license fees & royalty income
UNIQUE PRODUCTS THE PRODUCTS: Game changing, products in high demand for
both its hand sanitizer and cannabis product lines
THE SCIENCE: Backed by 20+ years of research & development
BACKED BY SCIENCE and patent protection allows for the exclusive development
& PATENTS and launch of other product lines
THE TEAM: Experienced team of executives, directors &
EXPERIENCED TEAM advisors
OVATION SCIENCE INC.
Stock Symbol: OVATION trades on the Canadian Securities Exchange under the
symbol CSE:OVAT. (November 2018) & OTCQB:OVATF (Feb 2021)
Capitalization:
Number of Shares Avg. Price $CDN
Issued & Outstanding 29,374,836
Warrants (Avg $0.51) 7,306,540 0.51 $ 3,726,335
Options (Avg $0.39) 1,750,000 0.39 $ 682,500
Fully Diluted 38,431,376 $ 4,408,835
Officers & Directors 8.4 M
Market Capital $8.8M
Cash (as of Mar1, 2021) $1.6M
12 Month Price Range $0.26 to $0.65
Business Model:
(1) Ovation generates online and wholesale revenue from the sale of its own product
lines including InvibeMD, Arlo CBD Beauty and DermSafe.
(2) Ovation’s out-licensing business model, with limited COGS, generates revenue
from multiple revenue streams including product development fees, licensing
fees, on-going royalties and sales of Invisicare polymer to its licensees.
DIRECTORS, EXECUTIVES & ADVISORS
OVATION SCIENCE INC.
OVATION has a diverse team of Board members, executives and advisors all with decades of
experience in the pharmaceutical industry and public markets.
BOARD OF DIRECTORS:
Business development, product R&D,
pharmaceutical & financial markets:
§ Terry Howlett, President, Director Co-Founder
§ Doreen McMorran, COO, Director Co-Founder
§ Logan Anderson, CFO, Director
§ Dave Ryan, Head of IR, Director
§ Ian Howard, Director
§ Joan Chypyha, Director
KEY SCIENTIST:
§ James Roszell, PhD, Head of Product Development, and developer of Invisicare®.
MEDICAL DERMATOLOGY ADVISORY BOARD:
Prominent international dermatologists:
§ Charles Lynde, MD. (CHAIR): Assoc. Professor Dept. of Medicine; University of Toronto
§ Jeffrey S. Dover, MD., FRCPC: Assoc. Clinical Professor of Dermatology; Yale University School of Medicine & Adjunct
Assoc. Professor of Dermatology; Brown Medical School
§Leon Kircik, MD., FAAD: Assoc. Clinical Professor of Dermatology; Indiana University Medical Center & Icahn School of
Medicine; Mount Sinai Medical Center
§Richard Thomas, MD., FRCPC: Dermatologist, London, UK (Formerly Clinical Assist. Professor; University of British Columbia)
OUR TECHNOLOGY – THE UNIQUE STORY
Invisicare is a powerful yet flexible combination of polymers that control how ingredients are
delivered to and through the skin
Unique Polymer Structure:
• Proprietary blend of hydrophilic and
hydrophobic polymers
• Developed from over 20 years of R&D
• Patents in 11 countries including Canada
& USA, Australia, Europe (4), China,
S. Korea, India & Hong Kong
• Patent filed for transdermal cannabis in
Canada and USA Feb 2021
• UNIQUE FORMULATION THAT BINDS
INGREDIENTS TO THE SKIN AND
DELIVERS THEM OVER TIME
OUR SCIENCE
Skin Binding Study – in vivo
(California Skin Research Institute (CSRI), CA)
• 30 Subjects Applied Invisicare product
• Forearms were scrubbed for 2 min’s. with
gauze saturated with 5% Ammonium
Hydroxide at intervals of 10 minutes, 2 hours
and 4 hours
• Results: Our product bound to skin >than 4
hours, even after 6 minutes of scrubbing.
Skin Moisture Study – in vivo
(BioScience Laboratories, MT)
• 20 Subjects: ½ applied Invisicare product
• 30 Second Wash & Rinse 10 x per Day for 5 days
• Results: 4 subjects without Invisicare dropped
out due to dermatitis (excessive dry skin).
TEWL and Corneal Moisture Readings
showed increased moisture with our
formulation.
OVATION SCIENCE – Product Division
#1
Cannabis (CBD / THC)THE PRODUCTS & THE RESULTS
DISRUPTIVE POSITIONING OVATION products are game changers in the infused cannabis marketplace,
replacing the “homemade” persona of current topical products with science-based, efficacious products that will
benefit consumers around the globe. We “super charge” actives; putting more cannabis to work:
THE RESULTS
§ OVATION’s 200mg topical product released more CBD to the skin
(40% vs 3% from a market leader that was tested)
§ OVATION’s 400mg transdermal products show up to an 81% penetration over 6 hours
(vs average penetration of other products reported at @10-25%)
(Results of a Franz Cell Diffusion Analysis)
TOPICAL DELIVERY TRANSDERMAL PENETRATION
3% vs 40% (Ovation) @ 2Hrs 10%-25% vs 81% (Ovation) @ 6 Hrs
% Comparison
of Active CBD
DeliveryNEVADA LICENSEE
§ Ovation’s Licensee in the USA: Lighthouse Strategies, LLC is a
Nevada/California-based cannabis marketing company
§ Rights include: exclusive for THC products in licensed Nevada dispensaries
only & non-exclusive for CBD in Nevada dispensaries.
§ Products Launched: Products developed by Ovation have been
launched under the brand name BASKiN.
BASKiN PRODUCTS:
§ #1 Selling Topical in Nevada Dispensaries
BASKiN + Extended Wellness Cream (400mg CBD/60ml -
transdermal); (Source: By # of Units sold - HeadSet.io, 2019)
§ BASKiN Extended Wellness Cream (150mg CBD/60ml - topical);
§ BASKiN Sport (300mg CBD/90 ml - transdermal);
§ BASKiN GLOW (50mg CBD / 500 mg THC/ 60ml – transdermal )
“Recreational” Cream.
§ NEW: BASKIN COMBO PRODUCTS: 1:1, 1:3 and 3:1OVATION’S CBD Health & Wellness / Beauty
INVIBE MD PRODUCTS: ARLO CBD BEAUTY:
www.invibemd.com www.arlocbdbeauty.com
§ Relief & Relax - 400mg/2oz § Anti-Aging Day / Night / Eye Cream
§ Troubled Skin - 200mg/2oz § Moisturizing Body Lotion
§ Keep Fit Sports Relief - 300mg/3oz FUTURE LINE EXTENSIONS:
§ Broad-spectrum sunscreen
§ Hand cream
§ Foot creamOVATION SCIENCE – Product Division
#2
DermSafe® Hand SanitizerDermSafe® Approvals & Studies
HEALTH CANADA / DERMATOLOGIST APPROVED:
§ DermSafe has been listed by Health Canada under “Disinfectants and hand sanitizers accepted
under COVID-19 interim measure” & has been approved for two Drug Identification Numbers (DIN)
for personal use and personal commercial use;
§Kills 99.9% of harmful germs. Independent studies verify that DermSafe will stay on the hands for
extended periods of time while continuing to kill a host of bacteria tested including MRSA, E-coli, C.
diff plus others and viruses including A/New Caledonia H1N1 (swine flu), H5N1 ( avian / bird flu) and
A/Panama H3N2 (influenza); these are all envelope viruses;
§An independent study has successfully proven the effectiveness of its DermSafe® hand sanitizer
lotion against a human coronavirus (Beta Coronavirus strain OC43), a surrogate for SARS-CoV-2
(the virus that causes COVID-19). The results showed that DermSafe demonstrated a 99.97%
reduction in active viral loads at two time points;
§DermSafe® has received the “Seal of Approval” from the Dermatology Review Panel™ (“DRP”). DRP
is a panel of Canadian dermatologists that provide an independent review of scientific data for non-
prescription products in order to authenticate a product’s claims
§Not made with alcohol therefore non-drying to the hands. It’s an added level of defense which
forms an invisible polymer glove on your hands;
§ Proven protection using chlorhexidine gluconate (CHG); an ingredient safely used in hospital soaps
worldwide for over 60 years. CHG is known for its ability to bind and stay on the skin1 and its ability
to kill gram-negative and gram-positive bacteria and viruses2.
1. Larson E, APIC guidelines for infection control practice: guideline for use of topical antimicrobial agents. AM J Infect Control 1988; 16(6):253-265.
2. Mangram AJ, et al., Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee.OVATION’S DermSafe Announcements
GLOBAL ORDERS / EXPANDING PRODUCTION:
§ CANADIAN ORDERS:
§ Distributors set-up across Canada to facilitate wholesale sales (BC/ AB/ON);
§ DermSafe sold online at www.DermSafe.com and www.Amazon.ca;
§ DermSafe® Hand Sanitizer is now available in select locations of Source For Sports, a
Canadian sporting goods retailer with over 130 locations across Canada;
§ Additional national Canadian retailer in progress – purchase order received;
§ Sold to veterinarians through CDMV.com, Canada’s leading distributor of products to
veterinary clinics across Canada;
§ Production in Canada & inventory on hand for further production.
§ INTERNATIONAL SALES:
§ Multiple sales orders for DermSafe for China & the United Kingdom;
§ Large Mexico distributor Grupo Venta International, S.A. de C.V. have placed multiple
orders selling to physicians, online & pursuing retail across Mexico;
§ Ovation signed license agreement for Israel with Gad Medical Equipment, a supplier
targeting all hospitals and clinics in Israel. They are seeking government approval.
Ovation is prepared, financed and dedicated to build DermSafe into a global brand and to help the fight
against COVID-19 & keep people safe.OVATION SCIENCE SUMMARY
§ GLOBAL DEMAND: We have global demand for DermSafe® Hand Sanitizer &
growth opportunities for Ovation’s cannabis products;
§ EXPANDING MARKETS:
§Hand sanitizers are here to stay & will continue to be in high demand;
§The cannabis market is surging as new US opportunities and demand
increases;
§ MULTIPLE REVENUE STREAMS: Ovation has multiple revenue streams from
Ovation’s own products and through licensees (DermSafe and CBD/THC
products)
§ BACKED BY SCIENCE & PATENTS: Our science & patents differentiate all of
our products from competitors
§ FINANCED & EXPERIENCED: Well financed and an
experienced team to implement our strategiesTHANK YOU CSE: OVAT / OTCQB: OVATF For more information contact: Terry Howlett, President & CEO Email: terry@ovationscience.com
You can also read
